Rabinowits G, Homsi J, Park S, Khushalani N, Panella T, Ellison D, Gentry R, Venna S, Strasswimmer J, Zuniga R, Chandra S, Ruiz E, Migden M, Ibrahim S, Mehta N, Inocencio T, He X, Zhang H, Gillis K, Pouliot J-F. CemiplimAb-rwlc Survivorship and Epidemiology (CASE): A prospective study of the safety and efficacy of cemiplimab in patients with advanced cutaneous squamous cell carcinoma (CSCC) in a real-world setting. J of Skin [Internet]. 2023 Mar. 13 [cited 2024 Jul. 4];7(2):s174. Available from: https://jofskin.org/33014/index.php/skin/article/view/1998